WHO ICTRP trial
Effect of Probiotic in treatment of GUM disease
CTRI/2017/05/008455 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2017/05/008455 |
|---|---|
| Public title | Effect of Probiotic in treatment of GUM disease |
| Scientific title | Evaluation of efficacy of Probiotic Bacillus coagulans in the treatment of Gingivitis - A Randomized Placebo controlled double blind trial |
| Primary sponsor | Dr Aftab Nawab |
| Secondary sponsors | Dr S Ravindra |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 4 |
| Countries | India |
| Conditions | Health Condition 1: null- Chronic Generalised Gingivitis |
| Interventions | Intervention1: "Bacillus coagulans" BD for 14 days.: NIL Control Intervention1: "Placebo" BD for 14 days.: NIL |
| Registration date | Mar 5, 2017 |
| Target size | 30 |
| Secondary IDs | U1111-1193-7041 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: